标题
MGMT testing—the challenges for biomarker-based glioma treatment
作者
关键词
-
出版物
Nature Reviews Neurology
Volume 10, Issue 7, Pages 372-385
出版商
Springer Nature
发表日期
2014-06-10
DOI
10.1038/nrneurol.2014.100
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Role of Gene Body Cytosine Modifications in MGMT Expression and Sensitivity to Temozolomide
- (2014) E. L. Moen et al. MOLECULAR CANCER THERAPEUTICS
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- In human glioblastomas transcript elongation by alternative polyadenylation and miRNA targeting is a potent mechanism of MGMT silencing
- (2013) Simone Kreth et al. ACTA NEUROPATHOLOGICA
- European Consensus Conference for external quality assessment in molecular pathology
- (2013) J. H. van Krieken et al. ANNALS OF ONCOLOGY
- Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group
- (2013) Jean-François Emile et al. BMC CANCER
- miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1
- (2013) Jie Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- MGMT-STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951
- (2013) M. J. van den Bent et al. CLINICAL CANCER RESEARCH
- Temozolomide-Mediated DNA Methylation in Human Myeloid Precursor Cells: Differential Involvement of Intrinsic and Extrinsic Apoptotic Pathways
- (2013) H. Wang et al. CLINICAL CANCER RESEARCH
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- External quality assessment ofBRAFmolecular analysis in melanoma
- (2013) Zandra C Deans et al. JOURNAL OF CLINICAL PATHOLOGY
- Improvement in the quality of molecular analysis ofEGFRin non-small-cell lung cancer detected by three rounds of external quality assessment
- (2013) Zandra C Deans et al. JOURNAL OF CLINICAL PATHOLOGY
- Assessing and Comparing the Performance of Molecular Diagnostic Tests
- (2013) Timothy J. O'Leary JOURNAL OF MOLECULAR DIAGNOSTICS
- Interlaboratory comparison of IDH mutation detection
- (2013) Martin J. van den Bent et al. JOURNAL OF NEURO-ONCOLOGY
- Phase 2 study of dose-intense temozolomide in recurrent glioblastoma
- (2013) A. D. Norden et al. NEURO-ONCOLOGY
- Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation
- (2013) W. Wick et al. NEURO-ONCOLOGY
- Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective
- (2013) B. Wiestler et al. NEURO-ONCOLOGY
- Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation
- (2013) W. Wick et al. NEUROLOGY
- miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells
- (2013) Cristina Quintavalle et al. PLoS One
- mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy
- (2013) M. Weiler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status
- (2012) Pierre Bady et al. ACTA NEUROPATHOLOGICA
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts
- (2012) G. J. Kitange et al. CLINICAL CANCER RESEARCH
- DNA methylation biomarkers in cancer: progress towards clinical implementation
- (2012) Thomas Mikeska et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
- (2012) Wolfgang Wick et al. LANCET ONCOLOGY
- Tumor-associated mutations inO6-methylguanine DNA-methyltransferase (MGMT) reduce DNA repair functionality
- (2012) Kristy L. Lamb et al. MOLECULAR CARCINOGENESIS
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
- (2012) Sevin Turcan et al. NATURE
- miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression
- (2012) W. Zhang et al. NEURO-ONCOLOGY
- Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma
- (2012) Arne Christians et al. PLoS One
- BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
- (2012) L Persano et al. Cell Death & Disease
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- Isocitrate dehydrogenase mutations: A challenge to traditional views on the genesis and malignant progression of gliomas
- (2011) Michael Weller et al. GLIA
- Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
- (2011) Jörg Felsberg et al. INTERNATIONAL JOURNAL OF CANCER
- Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
- (2011) Guido Reifenberger et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Study of Short-Course Radiotherapy Plus Concomitant and Adjuvant Temozolomide in Elderly Patients With Glioblastoma
- (2011) Giuseppe Minniti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial
- (2011) Jaime Gállego Pérez-Larraya et al. JOURNAL OF CLINICAL ONCOLOGY
- O6-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation
- (2011) Simone Kreth et al. PLoS One
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- Both base excision repair and O6-methylguanine-DNA methyltransferase protect against methylation-induced colon carcinogenesis
- (2010) S. Wirtz et al. CARCINOGENESIS
- Extent and Patterns of MGMT Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres
- (2010) D. Sciuscio et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
- (2010) James R. Perry et al. JOURNAL OF CLINICAL ONCOLOGY
- Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide
- (2010) N. Thon et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Interaction of Hypoxia-Inducible Factor-1α and Notch Signaling Regulates Medulloblastoma Precursor Proliferation and Fate
- (2010) Francesca Pistollato et al. STEM CELLS
- Long-Term Survival of Patients With Glioblastoma Treated With Radiotherapy and Lomustine Plus Temozolomide
- (2009) Martin Glas et al. JOURNAL OF CLINICAL ONCOLOGY
- MGMTPromoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
- (2009) Michael Weller et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
- Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas
- (2009) Sibille Everhard et al. NEURO-ONCOLOGY
- MGMT METHYLATION IS A PROGNOSTIC BIOMARKER IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
- (2009) E. R. Gerstner et al. NEUROLOGY
- Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults
- (2008) S. Kesari et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of Real-Time Methylation-Specific PCR to Determine O6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation in Glioma
- (2008) Ilse Vlassenbroeck et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme
- (2008) Angelique E. Sijben et al. JOURNAL OF NEURO-ONCOLOGY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More